The presence of antibodies to phosphatidylserine/prothrombin complex (aPS/PT) is associated with Raynaud phenomenon and migraine in patients with primary antiphospholipid syndrome (PAPS), according to findings published in Lupus.

A total of 67 consecutive patients with thrombotic PAPS were enrolled in this cross-sectional study. Using an enzyme-linked immunosorbent assay (ELISA), the investigators collected data on the presence of immunoglobulin G (IgG) and immunoglobulin M (IgM) aPS/PT antibodies and their associations with Raynaud phenomenon, migraine, and valvular lesions. Venous thrombosis was more common than isolated arterial thrombosis in this cohort (80.6% vs 4.5%, respectively; P <.0001).

In this patient population, a total of 29 (43.3%) patients had positive aPS/PT antibodies. Of these patients, there were more IgM antibodies than the IgG isotype (40.3% vs 17.9%, respectively; P =.014). Patients with triple antiphospholipid (aPL) antibodies were more likely to have aPS/PT antibodies compared with patients with either single or double aPL antibodies (85.7% vs 30.8% and 35.7%, respectively; P =.03). In addition, significantly greater frequencies of migraine and Raynaud phenomenon were observed among patients with PAPS who presented with positive aPS/PT antibodies (P =.0001).

This study included a limited patient dataset, and findings from this small patient population may not be generalizable to a larger patient population. Investigators also did not measure aPL and aPS/PT levels throughout the study period. Because of aPL and aPS/PT levels are known to fluctuate with time, this study is limited to associations found with measurements obtained at baseline only.

Continue Reading

Related Articles

Investigators of this study “suggest that aPS/PT antibodies could be involved in the pathogenesis of untypical vascular [antiphospholipid syndrome] manifestations,” yet little is known regarding the utility of aPS/PT antibodies as a biomarker for risk stratification.


Kopytek M, Natorska J, Undas A. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome [published online January 1, 2018]. Lupus. doi: 10.1177/0961203317751644